Search research articles
Contact Us
Filters
Showing results (71-80 of 138) with videos related to
Page
of 14
Sort By:
Pigment Cell & Melanoma Research
|
April 6, 2013
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression
Georgina V Long, James S Wilmott, Lauren E Haydu, et al.
Nano Letters
|
November 2, 2021
Correction to Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy
Yanjie Liu, Yan Zou, Chan Feng, et al.
The Journal of Investigative Dermatology
|
April 20, 2012
Absence of distinguishing senescence traits in human melanocytic nevi
Sieu L Tran, Sebastian Haferkamp, Lyndee L Scurr, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 21, 2024
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Wei Yen Chan, Jenny H Lee, Ashleigh Stewart, et al.
Nano Letters
|
February 5, 2020
Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy
Yanjie Liu, Yan Zou, Chan Feng, et al.
Molecular Neurodegeneration
|
June 25, 2010
First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia
Li Zhou, Eve Diefenbach, Ben Crossett, et al.
Molecular Oncology
|
January 31, 2014
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
Matteo S Carlino, Jason R Todd, Kavitha Gowrishankar, et al.
Molecular Cancer Therapeutics
|
September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine
James S Wilmott, Varsha Tembe, Julie R Howle, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 11, 2025
A scoping review of factors influencing the implementation of liquid biopsy for cancer care
Samran Sheriff, Maree Saba, Romika Patel, et al.
JAMA Oncology
|
February 10, 2018
Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti-Programmed Cell Death 1 Antibodies
Jenny H Lee, Georgina V Long, Alexander M Menzies, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 138) with videos related to
Sort By:
Page
of 14
Pigment Cell & Melanoma Research
|
April 6, 2013
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression
Georgina V Long, James S Wilmott, Lauren E Haydu, et al.
Nano Letters
|
November 2, 2021
Correction to Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy
Yanjie Liu, Yan Zou, Chan Feng, et al.
The Journal of Investigative Dermatology
|
April 20, 2012
Absence of distinguishing senescence traits in human melanocytic nevi
Sieu L Tran, Sebastian Haferkamp, Lyndee L Scurr, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 21, 2024
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Wei Yen Chan, Jenny H Lee, Ashleigh Stewart, et al.
Nano Letters
|
February 5, 2020
Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy
Yanjie Liu, Yan Zou, Chan Feng, et al.
Molecular Neurodegeneration
|
June 25, 2010
First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia
Li Zhou, Eve Diefenbach, Ben Crossett, et al.
Molecular Oncology
|
January 31, 2014
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
Matteo S Carlino, Jason R Todd, Kavitha Gowrishankar, et al.
Molecular Cancer Therapeutics
|
September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine
James S Wilmott, Varsha Tembe, Julie R Howle, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 11, 2025
A scoping review of factors influencing the implementation of liquid biopsy for cancer care
Samran Sheriff, Maree Saba, Romika Patel, et al.
JAMA Oncology
|
February 10, 2018
Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti-Programmed Cell Death 1 Antibodies
Jenny H Lee, Georgina V Long, Alexander M Menzies, et al.
Page
of 14